Liver dysfunction in AAV-mediated Hemophilia B gene therapy: Mechanisms and management strategies.

Hemophilia B, an X-linked recessive bleeding disorder caused by mutations in the gene encoding coagulation factor IX (FIX). Gene therapy using adeno-associated viral (AAV) vectors targeting hepatocytes has emerged as a promising treatment, enabling s…

Preview only. Read the full abstract at the source